Research programme: oral nucleoside analogues - Pharmasset

Drug Profile

Research programme: oral nucleoside analogues - Pharmasset

Alternative Names: Nucleos(t)ide analogue polymerase inhibitors - Pharmasset; PSI-352666; PSI-352879; PSI-353661; PSI-6206; PSI-6206 monophosphate; PSI-6206 phosphate; PSI-6206 triphosphate; PSI-661; PSI-879

Latest Information Update: 02 Feb 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Pharmasset
  • Class Nucleosides; Nucleotides; Purine nucleotides; Pyrimidine nucleotides; Small molecules
  • Mechanism of Action DNA-directed DNA polymerase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Hepatitis C; HIV infections

Most Recent Events

  • 02 Feb 2012 No development reported - Preclinical for Hepatitis C in USA (PO)
  • 02 Feb 2012 No development reported for HIV infections in USA (PO)
  • 17 Jan 2012 Pharmasset has been acquired by Gilead Sciences
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top